Michael Bartberger

Person

Sherman Oaks, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
AKT1 modulators
- Patent number 12,209,087
- Issue date Jan 28, 2025
- ALTEROME THERAPEUTICS, INC.
- Michael David Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
AKT1 modulators
- Patent number 11,999,730
- Issue date Jun 4, 2024
- ALTEROME THERAPEUTICS, INC.
- Michael David Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CIS-morpholinone and other compounds as MDM2 inhibitors for the tre...
- Patent number 11,407,721
- Issue date Aug 9, 2022
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzimidazole derivatives and their uses
- Patent number 11,332,459
- Issue date May 17, 2022
- Teijin Pharma Limited
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
KRAS G12C inhibitors and methods of using the same
- Patent number 11,096,939
- Issue date Aug 24, 2021
- Amgen Inc.
- Shon Booker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
KRAS G12C inhibitors and methods of using the same
- Patent number 11,045,484
- Issue date Jun 29, 2021
- Amgen Inc.
- Ryan Paul Wurz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
KRAS G12C inhibitors and methods of using the same
- Patent number 10,988,485
- Issue date Apr 27, 2021
- Amgen Inc.
- Ana Elena Minatti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,593,129
- Issue date Mar 14, 2017
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
- Patent number 9,376,425
- Issue date Jun 28, 2016
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,296,736
- Issue date Mar 29, 2016
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
- Patent number 8,686,011
- Issue date Apr 1, 2014
- Amgen Inc.
- Martin Henriksson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
- Patent number 8,541,592
- Issue date Sep 24, 2013
- Amgen Inc.
- Martin Henriksson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that interact with glucokinase regulatory protein for the...
- Patent number 8,431,563
- Issue date Apr 30, 2013
- Amgen Inc.
- Kate Ashton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta-secretase modulators and methods of use
- Patent number 8,163,766
- Issue date Apr 24, 2012
- Amgen Inc.
- Wenge Zhong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta-Secretase modulators and methods of use
- Patent number 7,973,047
- Issue date Jul 5, 2011
- Amgen Inc.
- Wenge Zhong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta-Secretase modulators and methods of use
- Patent number 7,872,009
- Issue date Jan 18, 2011
- Amgen Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta-secretase modulators and methods of use
- Patent number 7,838,676
- Issue date Nov 23, 2010
- Amgen Inc.
- Qiufen Xue
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
- Patent number 7,807,700
- Issue date Oct 5, 2010
- Amgen Inc.
- Martin Henriksson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta-secretase modulators and methods of use
- Patent number 7,745,484
- Issue date Jun 29, 2010
- Amgen Inc.
- Wenge Zhong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1
- Patent number 7,666,888
- Issue date Feb 23, 2010
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
- Patent number 7,253,196
- Issue date Aug 7, 2007
- Amgen, Inc.
- Martin Henriksson
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
AKT1 MODULATORS
- Publication number 20250092040
- Publication date Mar 20, 2025
- Alterome Therapeutics, Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20240300892
- Publication date Sep 12, 2024
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AKT1 MODULATORS
- Publication number 20240239797
- Publication date Jul 18, 2024
- Alterome Therapeutics, Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AKT1 MODULATORS
- Publication number 20240174667
- Publication date May 30, 2024
- Alterome Therapeutics, Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MCL1 INHIBITORS AND USES THEREOF
- Publication number 20230116602
- Publication date Apr 13, 2023
- California Institute of Technology
- Brendan M. O' Boyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KRAS G12C INHIBITORS AND USES THEREOF
- Publication number 20220227738
- Publication date Jul 21, 2022
- California Institute of Technology
- Justin A. Hilf
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRMT5 INHIBITORS AND USES THEREOF
- Publication number 20220194949
- Publication date Jun 23, 2022
- California Institute of Technology
- Brendan M. O'Boyle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20220169611
- Publication date Jun 2, 2022
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK INHIBITORS AND USES THEREOF
- Publication number 20220106325
- Publication date Apr 7, 2022
- California Institute of Technology
- Brendan M. O'Boyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERK INHIBITORS AND USES THEREOF
- Publication number 20220002294
- Publication date Jan 6, 2022
- California Institute of Technology
- Corey M. Reeves
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20210179560
- Publication date Jun 17, 2021
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZIMIDAZOLE DERIVATIVES AND THEIR USES
- Publication number 20200308145
- Publication date Oct 1, 2020
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
- Publication number 20200030324
- Publication date Jan 30, 2020
- Amgen Inc.
- Shon BOOKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
- Publication number 20190345169
- Publication date Nov 14, 2019
- Amgen Inc.
- Ana Elena MINATTI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
- Publication number 20190336514
- Publication date Nov 7, 2019
- Amgen Inc.
- Ryan Paul WURZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20190062276
- Publication date Feb 28, 2019
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...
- Publication number 20180354918
- Publication date Dec 13, 2018
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20170144971
- Publication date May 25, 2017
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20160137667
- Publication date May 19, 2016
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...
- Publication number 20160002185
- Publication date Jan 7, 2016
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140315895
- Publication date Oct 23, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER
- Publication number 20140235629
- Publication date Aug 21, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOK...
- Publication number 20140155415
- Publication date Jun 5, 2014
- Michael David Bartberger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140011796
- Publication date Jan 9, 2014
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE...
- Publication number 20120225854
- Publication date Sep 6, 2012
- Amgen Inc.
- Kate Ashton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1
- Publication number 20120010256
- Publication date Jan 12, 2012
- Biovitrum AB
- Martin HENRIKSSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20110319378
- Publication date Dec 29, 2011
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA-SECRETASE MODULATORS AND METHODS OF USE
- Publication number 20110118250
- Publication date May 19, 2011
- Amgen Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1
- Publication number 20110082107
- Publication date Apr 7, 2011
- Amgen Inc.
- Martin Henriksson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA-SECRETASE MODULATORS AND METHODS OF USE
- Publication number 20100222338
- Publication date Sep 2, 2010
- Amgen Inc.
- Wenge Zhong
- C07 - ORGANIC CHEMISTRY

Michael Bartberger

Person

Patents Grantslast 30 patents

AKT1 modulators

AKT1 modulators

CIS-morpholinone and other compounds as MDM2 inhibitors for the tre...

Benzimidazole derivatives and their uses

KRAS G12C inhibitors and methods of using the same

KRAS G12C inhibitors and methods of using the same

KRAS G12C inhibitors and methods of using the same

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1

Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1

Compounds that interact with glucokinase regulatory protein for the...

Beta-secretase modulators and methods of use

Beta-Secretase modulators and methods of use

Beta-Secretase modulators and methods of use

Beta-secretase modulators and methods of use

Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1

Beta-secretase modulators and methods of use

Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1

Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1

Patents Applicationslast 30 patents

AKT1 MODULATORS

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

AKT1 MODULATORS

AKT1 MODULATORS

MCL1 INHIBITORS AND USES THEREOF

KRAS G12C INHIBITORS AND USES THEREOF

PRMT5 INHIBITORS AND USES THEREOF

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

CDK INHIBITORS AND USES THEREOF

ERK INHIBITORS AND USES THEREOF

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

BENZIMIDAZOLE DERIVATIVES AND THEIR USES

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER

BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOK...

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE...

INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

BETA-SECRETASE MODULATORS AND METHODS OF USE

INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1

BETA-SECRETASE MODULATORS AND METHODS OF USE